Overview
Cystatin-C is an endogenous, non-glycosylated low-molecular-weight protein produced by all nucleated cells in the body, as described in the document. It is encoded by the CST3 gene and is released into the bloodstream at a constant rate, making it a reliable biological marker. It is freely filtered by the glomeruli of the kidneys, almost completely reabsorbed and metabolized in the proximal tubules, and normally not excreted in urine.
The document highlights that measurement of serum is used as a sensitive marker of glomerular filtration rate (GFR). Compared to traditional markers, cystatin-C is less affected by muscle mass, age, or gender, allowing more accurate estimation of kidney function, particularly in elderly individuals and patients with altered muscle mass. Because of these characteristics, It is valuable for early detection of renal impairment, monitoring kidney disease progression, and assessing overall renal health.
Symptoms
It does not produce symptoms. Symptoms arise due to conditions associated with elevated cystatin-C levels, primarily related to impaired kidney function, as outlined in the document.
Common symptoms linked to kidney dysfunction may include:
- Fatigue and weakness
- Reduced urine output
- Swelling of the face, hands, or feet
- Loss of appetite
Additional symptoms may include:
- Shortness of breath
- Nausea
- Difficulty concentrating
- Generalized discomfort
The document also notes that raised cystatin-C levels are associated with cardiovascular events and neurological conditions, where symptoms may include chest discomfort, reduced exercise tolerance, or cognitive changes. Symptom severity depends on the underlying disease and the extent of organ involvement rather than cystatin-C levels alone.
Causes
According to the document, elevated cystatin-C levels primarily result from reduced glomerular filtration rate, indicating impaired kidney function. Because cystatin-C production is constant, any decrease in kidney filtration leads to accumulation in the bloodstream.
Major causes include:
- Chronic kidney disease
- Acute kidney injury
- Renal disorders affecting glomerular filtration
The document further explains that cystatin-C levels may also be increased in:
- Cardiovascular disease
- Inflammatory conditions
- Autoimmune disorders
- Infections
- Cancer
- Diabetes and metabolic syndromes
It is also involved in inflammation, oxidative stress, and the regulation of cysteine proteases, linking it to broader systemic processes beyond renal function.
Risk Factors
Risk factors for abnormal levels are closely related to renal, cardiovascular, metabolic, and inflammatory conditions, as detailed in the document.
Major risk factors include:
- Decreased glomerular filtration rate
- Chronic kidney disease
- Obesity and increased body mass index
- Diabetes mellitus
Additional risk factors include:
- Cardiovascular disease and stroke risk
- Thyroid dysfunction
- Steroid use
- Autoimmune diseases
- Cancer
- HIV/AIDS
- Rheumatoid arthritis
- Certain metabolic conditions
The document emphasizes that it is particularly useful in individuals where creatinine-based GFR estimation may be misleading, such as elderly patients, obese individuals, and those with altered muscle mass.
Prevention
Abnormal cystatin-C levels cannot be directly prevented, as they reflect underlying disease processes rather than isolated causes. However, the document outlines preventive strategies focused on early detection, monitoring, and risk reduction.
Preventive approaches include:
- Early assessment of kidney function in high-risk individuals
- Regular monitoring of cystatin-C levels to detect early renal impairment
- Using cystatin-C-based GFR estimation when creatinine results are unreliable
- Monitoring cardiovascular risk in patients with mildly impaired kidney function
For accurate testing, the document emphasizes:
- No special patient preparation is required
- Collection of 3.0 mL blood in a plain red-capped tube
- Early separation of serum and prompt laboratory processing
